Serum Institute approves emergency Use of Covovax for Children aged 12-17
New Delhi, 9/3: The Indian drug regulator has approved limited emergency use of the Serum Institute of India’s anti-Covid-19 vaccine ‘Covid-19 Vaccine Covovax’. Giving this information on Wednesday, official sources said that the vaccine has been developed for children between the ages of 12 and 17. This will be the fourth anti-corona vaccine available in…
